Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
12-Dec-14 Shenyang-headquartered Chinese IT solutions and service provider Neusoft Corp says it intends to sign an agreement with an investor consortium including Chinese private equity firm Hony Capital and Goldman Sachs, to help the company transform its healthcare businesses. [image: China Money Network]
Read More
12-Dec-14 Non-communicable diseases were the cause of 78% of deaths in Latin America in 2008, estimated to rise to 84% by 2030. Obesity is at the heart of these deadly diseases, as a trigger for diabetes, high blood pressure, and high cholesterol. Mexico has the highest obesity growth rate in the world and the highest proportion of child obesity. [image: Global Health Intelligence]
Read More
11-Dec-14 Medtronic will turn over more than USD900 million in China this year, up from only USD50 million ten years ago. Its China strategy is multi-faceted, involving imports, local R&D, patient education and M&A. Despite this success, the advantage Medtronic - along with other foreign device makers - has carved out, is increasingly under pressure from local players, whose ability to innovate and drive costs down via frugal engineering is creating a new standard of excellence. [image: China Business Review]
Read More
10-Dec-14 Korea’s National Pension Service is ramping up to focus on investments in overseas healthcare markets in 2015, in the interest of income source diversification. Major Korean corporations such as Samsung have already started investing in hospitals abroad, for example in Turkey. [image: Business Korea]
Read More
10-Dec-14 India’s fast-growing medical devices market is dogged by tax and regulatory anomalies and malpractices, making it difficult for local manufacturers. Good news: These problems will be addressed soon by the Drugs & Cosmetics (Amendment) Bill 2014, which is expected to be passed in the current parliament session. [image: PV Sivakumar_The Hindu Business Line]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: